Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
NCT02279745
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Ralinepag
Sponsor
United Therapeutics